Correlation Between Nurix Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Kymera Therapeutics, you can compare the effects of market volatilities on Nurix Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Kymera Therapeutics.
Diversification Opportunities for Nurix Therapeutics and Kymera Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Nurix and Kymera is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Kymera Therapeutics
Given the investment horizon of 90 days Nurix Therapeutics is expected to generate 0.69 times more return on investment than Kymera Therapeutics. However, Nurix Therapeutics is 1.46 times less risky than Kymera Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 1,951 in Nurix Therapeutics on November 2, 2024 and sell it today you would earn a total of 51.00 from holding Nurix Therapeutics or generate 2.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nurix Therapeutics vs. Kymera Therapeutics
Performance |
| Timeline |
| Nurix Therapeutics |
| Kymera Therapeutics |
Nurix Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nurix Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite Nurix Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |